GPT2 and colorectal carcinoma: Previous studies have shown that When PIK3CA mutates, the glutamate pyruvate transaminase 2 in colorectal cancer (CRC) cells is significantly upregulated, thereby affecting the reprogramming of glutamine metabolism (Hao et al., 2016).